A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia.
- 2012-12
- RCT
- Schizophrenia research 142(1-3)
- K N Roy Chengappa
- Scott R Turkin
- Susan DeSanti
- Christopher R Bowie
- Jaspreet S Brar
- Patricia J Schlicht
- Sherry L Murphy
- Michelle L Hetrick
- Robert Bilder
- David Fleet
- PubMed: 23099060
- DOI: 10.1016/j.schres.2012.10.001
- High evidence
- Clinical
the L-carnosine group displayed significantly improved strategic efficiency and made fewer perseverative errors compared with placebo
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 2 g/day